MA31874B1 - Inhibiteurs de bêta-lactamases - Google Patents

Inhibiteurs de bêta-lactamases

Info

Publication number
MA31874B1
MA31874B1 MA32883A MA32883A MA31874B1 MA 31874 B1 MA31874 B1 MA 31874B1 MA 32883 A MA32883 A MA 32883A MA 32883 A MA32883 A MA 32883A MA 31874 B1 MA31874 B1 MA 31874B1
Authority
MA
Morocco
Prior art keywords
beta
inhibitors
lactamases inhibitors
lactamases
alpha
Prior art date
Application number
MA32883A
Other languages
Arabic (ar)
English (en)
Inventor
Christopher J Burns
Randy W Jackson
Rajesh Goswami
Hongyu Xu
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Publication of MA31874B1 publication Critical patent/MA31874B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention porte sur des acides alpha-aminoboroniques et sur leurs dérivés qui agissent tels des inhibiteurs de bêta-lactamases. L'invention porte également sur des compositions pharmaceutiques comportant des acides alpha-aminoboroniques et sur des procédés d'utilisation de celles-ci.
MA32883A 2007-11-13 2010-05-31 Inhibiteurs de bêta-lactamases MA31874B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US279707P 2007-11-13 2007-11-13
PCT/US2008/012706 WO2009064414A1 (fr) 2007-11-13 2008-11-13 Inhibiteurs de bêta-lactamases

Publications (1)

Publication Number Publication Date
MA31874B1 true MA31874B1 (fr) 2010-11-01

Family

ID=40344560

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32883A MA31874B1 (fr) 2007-11-13 2010-05-31 Inhibiteurs de bêta-lactamases

Country Status (21)

Country Link
US (2) US20100317621A1 (fr)
EP (2) EP2220097A1 (fr)
JP (2) JP2011503181A (fr)
KR (2) KR20100109901A (fr)
CN (2) CN101861324A (fr)
AR (2) AR069463A1 (fr)
AU (2) AU2008321444A1 (fr)
BR (2) BRPI0820531A2 (fr)
CA (2) CA2705393A1 (fr)
CO (1) CO6331427A2 (fr)
CR (1) CR11372A (fr)
EA (2) EA201000775A1 (fr)
EC (1) ECSP10010246A (fr)
GT (1) GT201000143A (fr)
IL (1) IL205205A0 (fr)
MA (1) MA31874B1 (fr)
MX (2) MX2010005252A (fr)
TN (1) TN2010000203A1 (fr)
TW (2) TW200936143A (fr)
WO (2) WO2009064413A1 (fr)
ZA (1) ZA201002467B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100120715A1 (en) * 2007-11-13 2010-05-13 Burns Christopher J Beta-lactamase inhibitors
US20100292185A1 (en) * 2009-05-12 2010-11-18 Burns Christopher J Beta-lactamase inhibitors
DK2603514T3 (en) 2010-08-10 2018-10-29 Rempex Pharmaceuticals Inc Cyclic boronic ester derivatives and their therapeutic uses
US9012491B2 (en) 2011-08-31 2015-04-21 Rempex Pharmaceuticals, Inc. Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
EP2793900B1 (fr) * 2011-12-22 2018-08-22 Ares Trading S.A. Dérivés d'acide boronique alpha-aminé, inhibiteurs selectives d'immunoproteasomes
BR112014016804A8 (pt) * 2012-01-06 2017-07-04 Univ California composições, métodos de uso e métodos de tratamento
US8933232B2 (en) * 2012-03-30 2015-01-13 Cubist Pharmaceuticals, Inc. 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
US9156858B2 (en) 2012-05-23 2015-10-13 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US10561675B2 (en) 2012-06-06 2020-02-18 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
CA2893943C (fr) * 2012-12-07 2021-03-02 VenatoRx Pharmaceuticals, Inc. Inhibiteurs de beta-lactamase
US9241947B2 (en) 2013-01-04 2016-01-26 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
EP2941247A4 (fr) 2013-01-04 2017-02-08 Rempex Pharmaceuticals, Inc. Dérivés d'acide boronique et leurs utilisations thérapeutiques
CN104994844A (zh) * 2013-01-04 2015-10-21 莱姆派克斯制药公司 硼酸衍生物及其治疗用途
US9101638B2 (en) 2013-01-04 2015-08-11 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
CN105101970B (zh) * 2013-01-10 2018-11-20 维纳拓尔斯制药公司 β-内酰胺酶抑制剂
EP2970340B1 (fr) 2013-03-14 2020-02-12 Venatorx Pharmaceuticals, Inc. Inhibiteurs de bêta-lactamase
WO2015171430A1 (fr) 2014-05-05 2015-11-12 Rempex Pharmaceuticals, Inc. Synthèse de sels boronate et utilisations de ceux-ci
EP3139930B1 (fr) * 2014-05-05 2024-08-14 Melinta Therapeutics, Inc. Sels et polymorphes de dérivés cycliques d'ester d'acide boronique, et leurs utilisations thérapeutiques
MX2016015093A (es) * 2014-05-19 2017-03-27 Rempex Pharmaceuticals Inc Derivados de acido boronico y sus usos terapeuticos.
EP3882252A1 (fr) 2014-06-11 2021-09-22 Venatorx Pharmaceuticals, Inc. Inhibiteurs de bêta-lactamase
US9511142B2 (en) 2014-06-11 2016-12-06 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
AU2015284307A1 (en) 2014-07-01 2017-02-02 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
KR102450583B1 (ko) * 2014-10-01 2022-10-04 메르크 파텐트 게엠베하 보론산 유도체
JP6835710B2 (ja) * 2014-10-01 2021-02-24 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ ボロン酸誘導体
ES2876287T3 (es) * 2014-10-01 2021-11-12 Merck Patent Gmbh Derivados del ácido borónico.
US10662205B2 (en) 2014-11-18 2020-05-26 Qpex Biopharma, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
WO2016100043A1 (fr) 2014-12-19 2016-06-23 Rempex Pharmaceuticals, Inc. Appareil et procédé à flux continu pour la production de dérivés d'acide boronique
US20180051041A1 (en) 2015-03-17 2018-02-22 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
CN108472284A (zh) 2015-09-11 2018-08-31 维纳拓尔斯制药公司 β-内酰胺酶抑制剂
WO2017100537A1 (fr) 2015-12-10 2017-06-15 VenatoRx Pharmaceuticals, Inc. Inhibiteurs de bêta-lactamases
UA123836C2 (uk) 2016-06-21 2021-06-09 Оріон Офтальмолоджі Ллс Аліфатичні похідні пролінаміду
PT3478693T (pt) 2016-06-30 2021-10-25 Qpex Biopharma Inc Derivados de ácido borónico e suas utilizações terapêuticas
WO2018027062A1 (fr) 2016-08-04 2018-02-08 VenatoRx Pharmaceuticals, Inc. Composés contenant du bore
CN110678186A (zh) 2017-03-06 2020-01-10 维纳拓尔斯制药公司 包含β-内酰胺酶抑制剂的固体形式和组合式组合物及其用途
US11267826B2 (en) 2017-05-26 2022-03-08 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
WO2018218190A1 (fr) * 2017-05-26 2018-11-29 VenatoRx Pharmaceuticals, Inc. Inhibiteurs de protéines de liaison à la pénicilline
WO2019009369A1 (fr) * 2017-07-06 2019-01-10 大日本住友製薬株式会社 Dérivé d'imine
TW201906616A (zh) * 2017-07-06 2019-02-16 日商大日本住友製藥股份有限公司 醯胺衍生物
CA3078627A1 (fr) 2017-10-11 2019-04-18 Qpex Biopharma, Inc. Derives d'acide boronique et synthese de ces derniers
EP3781576B1 (fr) 2018-04-20 2024-06-12 Qpex Biopharma, Inc. Dérivés d'acide boronique et leurs utilisations thérapeutiques
US20220125812A1 (en) * 2018-11-29 2022-04-28 VenatoRx Pharmaceuticals, Inc. Combination compositions comprising a beta-lactamase inhibitor and uses thereof
CN110156820B (zh) * 2019-04-25 2021-06-25 四川大学 一类巯基酰胺硼酸类衍生物及其作为mbl和/或sbl抑制剂的用途
CN114340639A (zh) 2019-06-19 2022-04-12 Qpex生物制药有限公司 硼酸衍生物及其治疗用途
CN113135944A (zh) * 2020-01-19 2021-07-20 首药控股(北京)有限公司 硼酸衍生物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7371729B2 (en) * 2002-09-09 2008-05-13 Trigen Limited Boronic acid salts useful in parenteral formulations
US20060084592A1 (en) * 2002-09-09 2006-04-20 Trigen Limited Peptide boronic acid inhibitors
US7271186B1 (en) * 2002-12-09 2007-09-18 Northwestern University Nanomolar β-lactamase inhibitors
AU2004256841A1 (en) * 2003-06-10 2005-01-20 Fulcrum Pharmaceuticals, Inc. Beta-lactamase inhibitors and methods of use thereof
US20100120715A1 (en) * 2007-11-13 2010-05-13 Burns Christopher J Beta-lactamase inhibitors
US20100292185A1 (en) * 2009-05-12 2010-11-18 Burns Christopher J Beta-lactamase inhibitors

Also Published As

Publication number Publication date
BRPI0820532A2 (pt) 2012-07-10
ZA201002467B (en) 2011-02-23
TW200930707A (en) 2009-07-16
GT201000143A (es) 2012-04-30
BRPI0820531A2 (pt) 2012-07-10
CN101983203A (zh) 2011-03-02
TW200936143A (en) 2009-09-01
AU2008321443A1 (en) 2009-05-22
AU2008321444A1 (en) 2009-05-22
AR069463A1 (es) 2010-01-27
TN2010000203A1 (en) 2011-11-11
EA201000775A1 (ru) 2010-12-30
JP2011503181A (ja) 2011-01-27
JP2011504468A (ja) 2011-02-10
WO2009064413A1 (fr) 2009-05-22
US20100317621A1 (en) 2010-12-16
MX2010005252A (es) 2011-04-11
CR11372A (es) 2010-09-14
EA201000774A1 (ru) 2010-12-30
MX2010005250A (es) 2010-11-05
CA2705389A1 (fr) 2009-05-22
EP2220096A1 (fr) 2010-08-25
ECSP10010246A (es) 2010-07-30
WO2009064414A1 (fr) 2009-05-22
CA2705393A1 (fr) 2009-05-22
EP2220097A1 (fr) 2010-08-25
US20100286092A1 (en) 2010-11-11
IL205205A0 (en) 2010-12-30
CO6331427A2 (es) 2011-10-20
AR069310A1 (es) 2010-01-13
KR20100113485A (ko) 2010-10-21
CN101861324A (zh) 2010-10-13
KR20100109901A (ko) 2010-10-11

Similar Documents

Publication Publication Date Title
MA31874B1 (fr) Inhibiteurs de bêta-lactamases
MA31433B1 (fr) Inhibiteurs de la p70 s6 kinase
MA30655B1 (fr) Composes organiques.
CY1113192T1 (el) Ενωσεις και μεθοδοι για την αναστολη της μιτωτικης προοδου μεσω αναστολης της κινασης aurora
EA200900613A1 (ru) Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
MA33197B1 (fr) Inhibiteurs de tripeptide époxy cétone protéases cristallines
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
CY1116754T1 (el) Παραγωγα νιτροκατεχολης ως αναστολεις της comt
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
WO2007019251A3 (fr) Inhibiteurs de la sphingosine kinase et leurs methodes d'utilisation
ATE495743T1 (de) Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
LTPA2018502I1 (lt) Per burną vartojamos kladribino kompozicijos
CY1118179T1 (el) Φαρμακευτικη συνθεση
CY1109673T1 (el) Συνεργεια των gos και της πολυφρουκτοζης
MA32150B1 (fr) Inhibiteurs heterocycliques de la stearoyl-coa desaturase
CR20110016A (es) Compuestos quimicos 251
SMT201300109B (it) Imidazopiridazincarbonitrili utili come inibitori di chinasi
ECSP077836A (es) Compuestos mejorados farmacocinéticamente
MX2012003555A (es) Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
BRPI0518228B8 (pt) inibidores de cinesina mitótica e uso dos mesmos
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
ATE461923T1 (de) Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
ECSP088763A (es) Nuevas combinaciones terapéuticas para el tratamiento de la depresión
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
ATE460922T1 (de) Zusammensetzungen und verfahren zur behandlung von b-zellen-malignomen